Crown Castle International Corp
Change company Symbol lookup
Select an option...
CCI Crown Castle International Corp
DOC Physicians Realty Trust
CYDVF Cypress Development Corp
KEYS Keysight Technologies Inc
HBAN Huntington Bancshares Inc
MMP Magellan Midstream Partners LP
VTI Vanguard Total Stock Market Index Fund ETF Shares
SKX Skechers USA Inc
RMGCW RMG Acquisition Equity III Warrant Exp 08 Feb 2026 *W EXP 02/08/2026
IKNA Ikena Oncology Inc
Go

Real Estate : Equity Real Estate Investment Trusts (REITs) | Large Cap Blend
Company profile

Crown Castle International Corp. is a real estate investment trust, which owns, operates and leases cell towers and route miles of fiber supporting small cells and fiber solutions across United States market. The Company's segments include Towers and Fiber, which includes both small cells and fiber solutions. Its business is providing access, including space or capacity, to its shared communications infrastructure via long-term contracts in various forms, including lease, license, sublease and service agreements. The Towers segment provides access, including space or capacity to its towers, which are geographically dispersed throughout the United States. The towers segment also reflects certain network services relating to its towers. The Fiber segment provides access, including space or capacity, to its route miles of fiber primarily supporting small cell networks and fiber solutions geographically dispersed throughout the United States.

Closing Price
$182.25
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
2,053,248
0

SPPI ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 1, 2021 in the Class Action Filed on Behalf of Spectrum Pharmaceuticals, Inc. Limited Shareholders

1:48 pm ET November 1, 2021 (Newsfile) Print

New York, New York--(Newsfile Corp. - November 1, 2021) -  The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) alleging that the Company violated federal securities laws.

Class Period: December 27, 2018 and August 5, 2021

Lead Plaintiff Deadline: November 1, 2021

No obligation or cost to you.

Learn more about your recoverable losses in SPPI:

https://www.kleinstocklaw.com/pslra-1/spectrum-pharmaceuticals-inc-loss-submission-form?id=20809&from=5

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/7092/101560_942384_logo.jpg

Spectrum Pharmaceuticals, Inc. NEWS - SPPI NEWS

CLASS ACTION CASE DETAILS: The filed complaint alleges that Spectrum Pharmaceuticals, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the manufacturing facility for ROLONTIS, an investigational granulocyte-colony stimulating factor analog, maintained deficient controls and/or procedures; (ii) the foregoing deficiencies decreased the likelihood that the Food and Drug Administration would approve the ROLONTIS biologics license application ("BLA") in its current form; (iii) Spectrum had therefore materially overstated the ROLONTIS BLA's approval prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

WHAT THIS MEANS TO YOU AS A SHAREHOLDER: If you have suffered a loss in Spectrum you have until November 1, 2021 to petition the court for lead plaintiff status. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you purchased Spectrum securities during the relevant period, you may be entitled to compensation without payment of any out-of-pocket fees.

HOW TO PROTECT YOUR FINANCIAL INTERESTS: For additional information about the SPPI lawsuit, please contact J. Klein, Esq. by telephone at 212-616-4899 or click this link.

ABOUT KLEIN LAW FIRM

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. The Klein Law Firm is a boutique litigation firm with experience in a wide range of areas including securities law, corporate finance and commercial litigation. Since 2011, our experienced attorneys have achieved superior results for our clients with a personalized focus. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.

Empire State Building

350 Fifth Avenue

59th Floor

New York, NY 10118

jk@kleinstocklaw.com

Telephone: (212) 616-4899

Fax: (347) 558-9665

www.kleinstocklaw.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/101560

comtex tracking

COMTEX_396190440/2523/2021-11-01T13:48:36

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.